Phase I/II clinical trial of Ariceum Therapeutics' 225Ac-SSO110 gets US FDA approval

Kelker Pharma introduces NUTRILINQ for patients using weight loss drugs

HUTCHMED receives full NMPA approval for ORPATHYS in China for MET exon 14 skipping NSCLC

BioArctic reports FDA acceptance of BLA for for subcutaneous maintenance dosing of Leqembi

Revvity and Element Biosciences partner to enhance neonatal sequencing for IVD testing

bioAffinity Technologies declares successful beta launch of CyPath Lung in Texas

Elicera Therapeutics receives ODD for ELC-100

Johnson & Johnson agrees acquisition of Intra-Cellular Therapies Inc

Bausch + Lomb Corporation acquires Whitecap Biosciences

Sanofi receives approval for Sarclisa in China for relapsed or refractory multiple myeloma

GSK to acquire IDRx for USD1.15bn to advance GIST treatment

hVIVO completes pilot study for hMPV challenge model

Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan receives US Priority Review for EGFR-mutated NSCLC

Virion Therapeutics enrols first two cohorts of Phase 1b clinical trial of VRON-0200 for HBV Functional Cure

Telix Pharmaceuticals signs asset purchase agreement with ImaginAb